Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis
- PMID: 37968755
- PMCID: PMC10648345
- DOI: 10.1186/s13018-023-04276-5
Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis
Erratum in
-
Correction: Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis.J Orthop Surg Res. 2024 Jan 5;19(1):36. doi: 10.1186/s13018-023-04500-2. J Orthop Surg Res. 2024. PMID: 38183058 Free PMC article. No abstract available.
Abstract
Background: Long-term glucocorticoid therapy may lead to osteoporosis (OP). Selenium (Se) is an essential microelement for human health and bone health. This study evaluated the association between dietary Se intake and the prevalence of OP and further explored the potential therapeutic effect of Se on glucocorticoid-induced OP (GIOP) in vivo and in vitro.
Methods: Data were collected from a population-based cross-sectional study conducted in our hospital. OP is diagnosed based on bone mineral density (BMD) measurements using compact radiographic absorptiometry. Dietary Se intake was assessed using a semi-quantitative food frequency questionnaire. The association between dietary Se intake and OP prevalence was analyzed by multivariable logistic regression. In animal experiments, male Sprague-Dawley rats were intramuscularly injected with dexamethasone (1 mg/kg) daily to induce GIOP, while different doses of Se were supplemented in rat drinking water for 60 d. BMD and biomechanical parameters of rat femur were measured. The histopathological changes of the femur were observed by HE staining, the number of osteoclasts was observed by TRAP staining, and OCN positive expression was detected by immunohistochemical staining. OPG, RANKL, Runx2, and BMP2 in rat femur were detected by Western blot. Bone turnover markers and oxidative stress markers were measured using commercial kits. MC3T3-E1 cells were induced to osteogenic differentiation, stimulated with DXM (100 μM), and/or treated with Se at different doses. Cell proliferation and apoptosis were assessed by CCK-8 and flow cytometry. ALP activity was detected by ALP staining and cell mineralization was observed by alizarin red staining.
Results: Participants with lower dietary Se intake had higher OP prevalence. Se supplementation improved BMD, biomechanical parameters, and histopathological changes of the femur in GIOP rats. Se supplementation also suppressed DXM-induced changes in bone turnover- and oxidative stress-related markers. Under DXM conditions, Se treatment induced MC3T3-E1 cell proliferation, ALP activity, and mineralization.
Conclusion: Lower Dietary Se intake is associated with OP prevalence. Moreover, Se takes a position in bone protection and anti-oxidative stress in GIOP models. Therefore, Se may be a complementary potential treatment for GIOP.
© 2023. The Author(s).
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures





Similar articles
-
Myricetin ameliorates glucocorticoid-induced osteoporosis through the ERK signaling pathway.Life Sci. 2018 Aug 15;207:205-211. doi: 10.1016/j.lfs.2018.06.006. Epub 2018 Jun 6. Life Sci. 2018. PMID: 29883721
-
Daphnetin ameliorates glucocorticoid-induced osteoporosis via activation of Wnt/GSK-3β/β-catenin signaling.Toxicol Appl Pharmacol. 2020 Dec 15;409:115333. doi: 10.1016/j.taap.2020.115333. Epub 2020 Nov 7. Toxicol Appl Pharmacol. 2020. PMID: 33171191
-
Ginsenosides Rg3 attenuates glucocorticoid-induced osteoporosis through regulating BMP-2/BMPR1A/Runx2 signaling pathway.Chem Biol Interact. 2016 Aug 25;256:188-97. doi: 10.1016/j.cbi.2016.07.003. Epub 2016 Jul 5. Chem Biol Interact. 2016. PMID: 27387537
-
[Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].Clin Calcium. 2013 Sep;23(9):1337-44. Clin Calcium. 2013. PMID: 23999371 Review. Japanese.
-
Autophagy as a target for glucocorticoid-induced osteoporosis therapy.Cell Mol Life Sci. 2018 Aug;75(15):2683-2693. doi: 10.1007/s00018-018-2776-1. Epub 2018 Feb 9. Cell Mol Life Sci. 2018. PMID: 29427075 Free PMC article. Review.
Cited by
-
Correction: Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis.J Orthop Surg Res. 2024 Jan 5;19(1):36. doi: 10.1186/s13018-023-04500-2. J Orthop Surg Res. 2024. PMID: 38183058 Free PMC article. No abstract available.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous